833-569-0440 info@pclabsdx.com

We are your trusted diagnostic lab

Patients Choice Laboratories was founded by healthcare providers and professionals in 2013.   PCL™ founders have over 60 years of laboratory and healthcare experience. The Laboratory Director is a licensed pathologist, who is board-certified both with American Board of BioAnalysis and American Society of Clinical Pathology.  The scientists responsible for performing the test methodology meet and exceed the levels of education and experience required by COLA and CLIA to perform high-complexity testing. Testing methods utilized are supported, verified and provide high confidence is consistency and accuracy. All tests are reviewed and approved prior to release and patient confidentiality is monitored and maintained 24 hours a day

Meet the Team

Brad Moss | President

Brad Moss serves as President of Patients Choice Laboratories. A veteran of the healthcare industry, Moss brings in excess of twenty years’ experience to Patients Choice Laboratories. With the honor of serving as President and responsible for overseeing business development, health economics, strategic partnerships, and related activities within the company, Moss brings innovative leadership and growth expertise to his position.

Prior to Patients Choice Laboratories, Moss served as the Chief Business Officer for SeKayi Management, a $10M healthcare management organization. While at SeKayi, Moss oversaw three subsidiaries that managed over 500,000 patients in four states. Before SeKayi, Moss served as National Director of Sales for DailyMed Pharmacy, a subsidiary Arcadia Resources, Inc., (NYSE Amex: KAD), a ~$100M healthcare provider. While at Arcadia, Moss led corporate sales for DailyMed, a comprehensive Medication Therapy Management and medication adherence program.
Having received his Bachelor of Science degree from Eastern Illinois University in 1996, Moss completed his MBA in 2008 from the University of Illinois.

Trevor Eagleson | CFO

Trevor Eagleson, Chief Financial Officer, is focused on the financial activities of the laboratory including financial planning and analysis, controllership, internal audit, tax, treasury and risk management. Mr. Eagleson has a Bachelor of Science degree in Accounting from the Kelley School of Business, Indiana University Bloomington.  Previously he was with BrightPoint, Inc. (formerly NASDAQ:CELL, now a subsidiary of Ingram Micro:IM), a leader and innovator in technology and supply chain services. He started his career with the public accounting firm, Ernst & Young, where he progressed from Staff Auditor to Senior Manager in the Entrepreneurial Services Group. Mr. Eagleson is also co-owner and Chief Financial Officer of ACE Game Room Gallery.

Jonathan Reeser, MBA / Toxicology Technical Supervisor

Jonathan Reeser is Patients Choice Laboratories Toxicology technical supervisor. Responsible for technical oversight in the laboratory, oversight of method development, responding to clients questions concerning test results, and the development of standard operating procedures.

Jonathan has a vast amount of health care experience spanning more than a decade. He spent over half of that decade working on the patient care side. In recent years, he has put his focus on patient testing in an effort to improve the quality of patient care. Jonathan has earned a Bachelors of Science degree in Biology from Indiana State University, a Bachelors of Science degree in Chemistry from Indiana University – Purdue University of Indianapolis, and completed his MBA from Indiana Wesleyan University.

Zhijing Huang, PhD | Molecular Technology

Zhijing Huang joined Patients Choice Laboratories after receiving her PH.D. in Microbiology from Indiana University in Bloomington.  Her research is focused on the host response of viral infections.

Dr. Huang has published her work in multiple peer-reviewed journals and presented her study from IU and PCL at national and international conferences.  At Patients Choice, she is now working on the development of LDTs and implementation of new technologies to expand the test menu of the Molecular Department.

Stephen Barlow, MD | Medical Director

Dr. Barlow has over 30 years of experience as both a clinical and anatomic pathologist. He is a lifelong resident of Indiana, graduating from Bedford High School and receiving his Bachelor of Science in Biological Sciences from Indiana University Bloomington in 1971. He received his MD at the Indiana School of Medicine in Indianapolis in 1975, then moved to an internship at St Vincent Hospital. He ultimately culminated his board certification in both clinical and anatomic pathology by the American Board of Pathology in 1983 (until present). During his professional career, Dr. Barlow has served over 20 years as a Laboratory Director and Pathologist at Dunn Memorial Hospital in Bedford, Indiana and other Medical Directorships at Bedford Regional Medical Center/IU Hospital, Winona Memorial Hospital, Monroe Hospital Laboratory and St. Vincent Dunn Hospital laboratories. Dr. Barlow has been an active member of the medical community and also a civic leader in Indiana.

Safedin (Sajo) Beqaj, PhD, HCLD, CC (ABB) | Clinical Consultant

Dr. Sajo Beqaj is board certified in molecular diagnostics and licensed as a Bioanalyst and High Complexity Laboratory Director. He has been practicing as a laboratory director since 2005.

Prior to PCL, he served from 2011-2016 as a technical director and principal investigator at Pathology, Inc. Torrance, California. During this time, Dr. Beqaj was responsible for building a successful and efficient clinical laboratory that was later acquired by LabCorp. From 2008-2011 he served as Laboratory Director for Clinical Pathology at DCL Medical Laboratories, Indianapolis, Indiana, where he was responsible for clinical technical operations including development and implementation of new tests and technologies. He held the position of Laboratory Director in molecular diagnostics for Path Group Labs, Nashville, Tennessee from 2005-2008. Prior to his clinical experience, he was a Research Assistant Professor at Northwestern University, Chicago, Illinois until 2005.

Dr. Baqaj received his Ph.D. in Pathology from Wayne State University Medical School, Detroit, Michigan. He performed his post-doctoral fellowship at Abbott Laboratories from 2001-2003.

Dr. Beqaj has taught in several academic institutions and has published numerous medical textbook chapters and journal articles. He has conducted clinical trials for several well-known pharmaceutical and diagnostic companies, and has presented various scientific clinical abstracts and presentations. He is a member of several medical and scientific associations including the Association of Molecular Pathology, American Association of Clinical Chemistry and the Pan Am Society for Clinical Virology. He has served on a number of clinical laboratory regulatory and scientific committees, and has assisted several laboratories and physicians as a Clinical Laboratory Consultant.